News | April 16, 2026
Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Subscribe To Our Newsletter & Stay Updated
